Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Recombinant inhibitor of human plasma kallikrein

EU orphan designation number: EU/3/02/126
Active ingredient: Recombinant inhibitor of human plasma kallikrein
Indication: treatment of angioedema
Sponsor: Dyax s.a.
159B Oudemoeder, 4880 Aubel, België

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
23/12/2002 Orphan designation EMEA/OD/043/02 (2002)5443 of 18/12/2002
28/04/2009 Change of name and/or address of sponsor
17/06/2014 Removal of orphan designation from Community Register